Topical Lidocaine for Pain Control With Intrauterine Device (IUD) Insertion
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Intrauterine contraception is a very effective, long term, reversible form of birth control,
and is increasingly used in young, nulliparous patients. However, there is potential for pain
with insertion of an Intrauterine Device (IUD) - particularly in patients without a previous
history of vaginal delivery. The potential pain associated with insertion is often a
significant barrier for patients when choosing and IUD for contraception. Several methods of
pain control have been studied, but none have been shown to reduce pain at time of insertion.
Our research question is to determine if 2% topical lidocaine gel, instilled into the
cervical canal, will reduce maximum pain at time of insertion of a popular IUD (Mirena
Intrauterine System) in young, nulliparous patients. This will be studied in a randomized,
double-blind placebo-controlled trial.